Details for New Drug Application (NDA): 210194
✉ Email this page to a colleague
The generic ingredient in ESTRADIOL is estradiol valerate. There are six drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the estradiol valerate profile page.
Summary for 210194
| Tradename: | ESTRADIOL |
| Applicant: | Padagis Israel |
| Ingredient: | estradiol |
| Patents: | 0 |
Pharmacology for NDA: 210194
| Mechanism of Action | Estrogen Receptor Agonists |
Medical Subject Heading (MeSH) Categories for 210194
Suppliers and Packaging for NDA: 210194
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| ESTRADIOL | estradiol | CREAM;VAGINAL | 210194 | ANDA | AvKARE | 42291-426 | 42291-426-42 | 1 TUBE in 1 CARTON (42291-426-42) / 42.5 g in 1 TUBE |
| ESTRADIOL | estradiol | CREAM;VAGINAL | 210194 | ANDA | Padagis Israel Pharmaceuticals Ltd | 45802-097 | 45802-097-35 | 1 TUBE in 1 CARTON (45802-097-35) / 42.5 g in 1 TUBE |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | CREAM;VAGINAL | Strength | 0.01% | ||||
| Approval Date: | Jan 22, 2018 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
